Lin C - Search Results

1

Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.

Huang L, Xu R, Li W, Lv L, Lin C, Yang X, Yao Y, Saw PE, Xu X. Huang L, et al. Among authors: lin c. Acta Biomater. 2023 May;162:98-109. doi: 10.1016/j.actbio.2023.03.014. Epub 2023 Mar 16. Acta Biomater. 2023. PMID: 36931417

2

Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy.

Saw PE, Yao H, Lin C, Tao W, Farokhzad OC, Xu X. Saw PE, et al. Among authors: lin c. Nano Lett. 2019 Sep 11;19(9):5967-5974. doi: 10.1021/acs.nanolett.9b01660. Epub 2019 Aug 7. Nano Lett. 2019. PMID: 31381852

3

A polyprodrug-based nanoplatform for cisplatin prodrug delivery and combination cancer therapy.

Lin C , Tao Y , Saw PE , Cao M , Huang H , Xu X . Lin C , et al. Chem Commun (Camb). 2019 Nov 19;55(93):13987-13990. doi: 10.1039/c9cc06567a. Chem Commun (Camb). 2019. PMID: 31687673

4

Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy.

Li S, Saw PE, Lin C, Nie Y, Tao W, Farokhzad OC, Zhang L, Xu X. Li S, et al. Among authors: lin c. Biomaterials. 2020 Mar;234:119760. doi: 10.1016/j.biomaterials.2020.119760. Epub 2020 Jan 6. Biomaterials. 2020. PMID: 31945619

5

Shape Matters: Comprehensive Analysis of Star-Shaped Lipid Nanoparticles.

Cao S, Liu X, Li X, Lin C, Zhang W, Tan CH, Liang S, Luo B, Xu X, Saw PE. Cao S, et al. Among authors: lin c. Front Pharmacol. 2020 Apr 30;11:539. doi: 10.3389/fphar.2020.00539. eCollection 2020. Front Pharmacol. 2020. PMID: 32425785 Free PMC article.

6

TME-Responsive Multistage Nanoplatform for siRNA Delivery and Effective Cancer Therapy.

Cao S, Lin C, Li X, Liang Y, Saw PE. Cao S, et al. Among authors: lin c. Int J Nanomedicine. 2021 Aug 27;16:5909-5921. doi: 10.2147/IJN.S322901. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34475756 Free PMC article. Review.

7

Corrigendum to "Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy" [Biomater. 234 (2020) 119760].

Li S, Saw PE, Lin C, Nie Y, Tao W, Farokhzad OC, Zhang L, Xu X. Li S, et al. Among authors: lin c. Biomaterials. 2023 Feb;293:121951. doi: 10.1016/j.biomaterials.2022.121951. Epub 2022 Dec 14. Biomaterials. 2023. PMID: 36525705 No abstract available.

8

Bioactive Nanotherapeutic Ultrasound Contrast Agent for Concurrent Breast Cancer Ultrasound Imaging and Treatment.

Fang J, Tan J, Lin L, Cao Y, Xu R, Lin C, He G, Xu X, Xiao X, Jiang Q, Saw PE. Fang J, et al. Among authors: lin c, lin l. Adv Healthc Mater. 2024 Oct;13(26):e2401436. doi: 10.1002/adhm.202401436. Epub 2024 Jul 2. Adv Healthc Mater. 2024. PMID: 38923231

9

Advances in targeted delivery of mRNA into immune cells for enhanced cancer therapy.

Huang L, Huang Z, Zhang Y, Lin C, Zhao Z, Li R, Saw PE, Xu X. Huang L, et al. Among authors: lin c. Theranostics. 2024 Sep 3;14(14):5528-5550. doi: 10.7150/thno.93745. eCollection 2024. Theranostics. 2024. PMID: 39310113 Free PMC article. Review.

10

The specific killing effect of matrine on castration-resistant prostate cancer cells by targeting the Akt/FoxO3a signaling pathway.

Bai S, Chen T, Yu X, Luo M, Chen X, Lin C, Lai Y, Huang H. Bai S, et al. Among authors: lin c. Oncol Rep. 2017 May;37(5):2819-2828. doi: 10.3892/or.2017.5510. Epub 2017 Mar 16. Oncol Rep. 2017. PMID: 28440481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,936 results

Search Page

Filters